Taiwan’s Tri-Service General Hospital has developed a highly precise method utilizing “Neptune’s Blade” to ablate prostate cancer cells. This innovative technique, employing focused energy, offers a more targeted approach compared to traditional treatments. Early results indicate a reduced risk of post-operative urinary incontinence and sexual dysfunction, significant concerns for patients undergoing prostate cancer therapy. The method precisely eliminates cancerous tissue while minimizing damage to surrounding healthy areas. This represents a significant advancement in prostate cancer treatment within Taiwan and potentially globally. It addresses the rising incidence of prostate cancer, currently the third most common cancer among Taiwanese men. Further research and wider implementation are anticipated following these promising outcomes.